Gastrointestinal Dysmotility on Aspiration Risk

Status Not yet recruiting

Clinical Trial Summary

The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05455359
Study type	Interventional
Source	Boston Children's Hospital
Contact	Rachel Rosen, MD
Phone	617-355-0897
Email	rachel.rosen@childrens.harvard.edu
Status	Not yet recruiting
Phase	Phase 4
Start date	July 18, 2022
Completion date	July 18, 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06025773` - A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121	Phase 1
Recruiting	`NCT06280664` - Efficacy Of Hiatal Closure For GERD
Recruiting	`NCT05359965` - Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF	N/A
Completed	`NCT04202692` - Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment	N/A
Active, not recruiting	`NCT03646045` - Transpyloric Feeding for Prevention of Micro-aspiration
Recruiting	`NCT06430047` - Efficacy and Safety of EsoDuo®	Phase 4
Completed	`NCT04268719` - Near Focus NBI-Driven Artificial Intelligence for the Diagnosis of Gastro-Oesophageal Reflux Disease
Active, not recruiting	`NCT04614974` - Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia	Phase 1/Phase 2
Terminated	`NCT05579444` - Systems Biology of Gastrointestinal and Related Diseases
Recruiting	`NCT03868267` - Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting
Terminated	`NCT04028466` - Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features	Phase 4
Active, not recruiting	`NCT05371717` - Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite	N/A
Recruiting	`NCT05066594` - Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)
Completed	`NCT03476265` - Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motility	N/A
Completed	`NCT03143608` - GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery	N/A
Completed	`NCT04436159` - Partial Versus Total Fundoplication in the Surgical Repair of Para-esophageal Hernia.	N/A
Completed	`NCT03258528` - Effect of Right Lateral Position on Ventilated Preterm Neonates	N/A
Active, not recruiting	`NCT04500288` - The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux Disease: A Prospective Pilot Study	N/A
Completed	`NCT04262648` - Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns	N/A
Recruiting	`NCT04846010` - Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2	Phase 1/Phase 2